Ulcerqative colitis
Conditions
Interventions
Observation after spraying indigocarmine over the entire colon during surveillance colonoscopy for patients with ulcerative colitis who have given consent.
Observation using LCI during surveillance
Sponsors
Nagoya University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with disease duration of more than 6 years Patients with total or left-sided colitis Patients who have not undergone surveillance colonoscopy in the past 6 months Patients with a Partial Mayo score of 4 or less Patients who understand the study and have given written consent
Exclusion criteria
Exclusion criteria: Patients with severe acute inflammation on endoscopic findings Pregnant patients Patients with extremely poor general condition, intestinal perforation, pancreatitis, respiratory disease, circulatory disease, acquired hemophilia, stenosis, large ulcer or tumor, or other conditions in which the risk of performing endoscopy exceeds the benefit Patients with serious functional impairment of the heart, lungs, kidneys, or liver Patients with bradycardia or atrioventricular block Patients who are incapable of self-judgment Patients with Poor and Inadequate cleanliness (Aronchick score) Patients deemed inappropriate by the physician in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| detection rate | — |
Countries
Japan
Contacts
Public ContactKeisuke Oiwa
Nagoya University Hospital Department of Gastroenterology and Hepatology
Outcome results
None listed